melanoma

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶From collaboration to innovation: How multidisciplinary teams and clinical trials are transforming melanoma careMelanoma Insights for Professionals40:22Notes
   +Listen later
2. 2▶Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology SummitDermatologic Oncology Update50:39Notes
   +Listen later
3. 3▶Redefining Immunotherapy (Ep. 5): Hype vs Reality: The Future of ImmunotherapyMelanoma Insights for Professionals22:12Notes
   +Listen later
4. 4▶Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy: Expert PerspectivesMelanoma Insights for Professionals27:38Notes
   +Listen later
5. 5▶[Trailer] Redefining Immunotherapy (Ep. 4): Melanoma Treatment StrategyMelanoma Insights for Professionals1:15Notes
   +Listen later
6. 6▶Redefining Immunotherapy (Ep. 3): Immunotherapy Toxicity: Prevention, Early Recognition and Management to Optimise OutcomeMelanoma Insights for Professionals24:54Notes
   +Listen later
7. 7▶Redefining Immunotherapy (Ep. 2): Predict, Treat, Monitor: The Quest for Smarter Immunotherapy DecisionsMelanoma Insights for Professionals23:06Notes
   +Listen later
8. 8▶Redefining Immunotherapy (Ep. 1): Beyond the Tumour: Rethinking Cancer in the Immunotherapy EraMelanoma Insights for Professionals25:11Notes
   +Listen later
9. 9▶Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil KhushalaniDermatologic Oncology Update1:03:49Notes
   +Listen later
10. 10▶Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell CarcinomasDermatologic Oncology Update2:13:32Notes
    +Listen later
11. 11▶After the diagnosis: Getting follow-up care right in melanomaMelanoma Insights for Professionals29:52Notes
    +Listen later
12. 12▶Overdiagnosis or early detection? The controversy of melanoma in situMelanoma Insights for Professionals40:09Notes
    +Listen later
13. 13▶Utilising melanoma risk prediction tools for newly diagnosed patientsMelanoma Insights for Professionals31:39Notes
    +Listen later
14. 14▶Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual MeetingDermatologic Oncology Update1:00:57Notes
    +Listen later
15. 15▶Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology SummitDermatologic Oncology Update51:15Notes
    +Listen later
16. 16▶Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L MoertelDermatologic Oncology Update49:28Notes
    +Listen later
17. 17▶Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell TumorDermatologic Oncology Update1:03:55Notes
    +Listen later
18. 18▶Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated LiposarcomaDermatologic Oncology Update1:15:13Notes
    +Listen later
19. 19▶Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin CancersDermatologic Oncology Update59:36Notes
    +Listen later
20. 20▶Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual ReviewDermatologic Oncology Update1:06:09Notes
    +Listen later